ArticleImmuno-oncology technology2025

A phase II study of nivolumab, ipilimumab, and radiation in combination with influenza vaccine in patients with pancreatic cancer (INFLUENCE).

I M Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.